33462 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92
    Cell Signaling Technology Inc anti flt3
    ( A ) MA plot showing genes differentially expressed in MV4;11 cells treated with 100 nM pinometostat or DMSO 7 days as log 2 -mean of expression (FPKM) of the DMSO and pinometostat-treated samples versus the log 2 -fold change of the mean normalized pinometostat versus DMSO-treated FPKM for three independent replicates. Red represents genes that meet the significance threshold, with an FDR-adjusted p ≤ 0.5. ( B ) Venn diagram depicting overlapping genes between those downregulated by 100 nM pinometostat and MV4;11 MLL-AF4 targets identified by , p-value computed by two-tailed Fisher Exact test. ( C ) Venn diagram displaying the overlap between genes downregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and treatment with 3 µM of the pinometostat-related compound EPZ004777 for 6 days . p-Value computed by two-tailed Fisher Exact test. ( D ) Bar plot depicting upregulated genes with the highest fold changes from RNA-seq analysis of three independent experiments of DMSO- (blue) or pinometostat-treated (red) MV4;11 cells with uncertainty presented as the standard deviation computed by CuffDiff with immune response genes outlined in gray. ( E ) RT-qPCR analysis showing the fold-change for HLA-DRA, HLA-DRB1 , and CIITA gene expression in MV4;11 cells ± 100 nM pinometostat treatment for 7 days. Results are shown as mean ± S.E.M. of three independent experiments. Student’s t-test (*****p ≤ 0.00001). ( F ) Bar plot depicting the top pinometostat-downregulated genes from the RNA-seq analysis that are previously described MLL-AF4 targets including the oncogenes MEF2C, <t>FLT3</t> , and PBX3 . ( G ) RT-qPCR analysis of MEF2C, FLT3 , and PBX3 expression in MV4;11 cells ± with 100 nM pinometostat for 7 days. Results are displayed as mean fold-change ± S.E.M. of three independent experiments; Student’s t-test (**** p ≤ 0.0001). ( H ) Western blot for FLT3 with RBBP5 as loading control in MV4;11 cells treated with 100 nM pinometostat for 5 or 7 days. ( I ) Venn diagram displaying the overlap between genes upregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and genes downregulated in leukemic cells from patients with FLT3-ITD vs normal FLT3 karyotypically normal AML . p-Value computed by two-tailed Fisher Exact test.
    Anti Flt3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti flt3/product/Cell Signaling Technology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti flt3 - by Bioz Stars, 2023-06
    92/100 stars
      Buy from Supplier

    93
    ATCC l longbeachae serogroup 1 atcc 33462
    Bacterial strains and plasmids
    L Longbeachae Serogroup 1 Atcc 33462, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/l longbeachae serogroup 1 atcc 33462/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    l longbeachae serogroup 1 atcc 33462 - by Bioz Stars, 2023-06
    93/100 stars
      Buy from Supplier

    86
    ATCC few atcc 33462 bacteria
    Analysis of virulence of L. longbeachae serogroup 1 strains in a guinea pig model of infection
    Few Atcc 33462 Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/few atcc 33462 bacteria/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    few atcc 33462 bacteria - by Bioz Stars, 2023-06
    86/100 stars
      Buy from Supplier

    86
    ATCC legionella longbeachae
    Analysis of virulence of L. longbeachae serogroup 1 strains in a guinea pig model of infection
    Legionella Longbeachae, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/legionella longbeachae/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    legionella longbeachae - by Bioz Stars, 2023-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) MA plot showing genes differentially expressed in MV4;11 cells treated with 100 nM pinometostat or DMSO 7 days as log 2 -mean of expression (FPKM) of the DMSO and pinometostat-treated samples versus the log 2 -fold change of the mean normalized pinometostat versus DMSO-treated FPKM for three independent replicates. Red represents genes that meet the significance threshold, with an FDR-adjusted p ≤ 0.5. ( B ) Venn diagram depicting overlapping genes between those downregulated by 100 nM pinometostat and MV4;11 MLL-AF4 targets identified by , p-value computed by two-tailed Fisher Exact test. ( C ) Venn diagram displaying the overlap between genes downregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and treatment with 3 µM of the pinometostat-related compound EPZ004777 for 6 days . p-Value computed by two-tailed Fisher Exact test. ( D ) Bar plot depicting upregulated genes with the highest fold changes from RNA-seq analysis of three independent experiments of DMSO- (blue) or pinometostat-treated (red) MV4;11 cells with uncertainty presented as the standard deviation computed by CuffDiff with immune response genes outlined in gray. ( E ) RT-qPCR analysis showing the fold-change for HLA-DRA, HLA-DRB1 , and CIITA gene expression in MV4;11 cells ± 100 nM pinometostat treatment for 7 days. Results are shown as mean ± S.E.M. of three independent experiments. Student’s t-test (*****p ≤ 0.00001). ( F ) Bar plot depicting the top pinometostat-downregulated genes from the RNA-seq analysis that are previously described MLL-AF4 targets including the oncogenes MEF2C, FLT3 , and PBX3 . ( G ) RT-qPCR analysis of MEF2C, FLT3 , and PBX3 expression in MV4;11 cells ± with 100 nM pinometostat for 7 days. Results are displayed as mean fold-change ± S.E.M. of three independent experiments; Student’s t-test (**** p ≤ 0.0001). ( H ) Western blot for FLT3 with RBBP5 as loading control in MV4;11 cells treated with 100 nM pinometostat for 5 or 7 days. ( I ) Venn diagram displaying the overlap between genes upregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and genes downregulated in leukemic cells from patients with FLT3-ITD vs normal FLT3 karyotypically normal AML . p-Value computed by two-tailed Fisher Exact test.

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet: ( A ) MA plot showing genes differentially expressed in MV4;11 cells treated with 100 nM pinometostat or DMSO 7 days as log 2 -mean of expression (FPKM) of the DMSO and pinometostat-treated samples versus the log 2 -fold change of the mean normalized pinometostat versus DMSO-treated FPKM for three independent replicates. Red represents genes that meet the significance threshold, with an FDR-adjusted p ≤ 0.5. ( B ) Venn diagram depicting overlapping genes between those downregulated by 100 nM pinometostat and MV4;11 MLL-AF4 targets identified by , p-value computed by two-tailed Fisher Exact test. ( C ) Venn diagram displaying the overlap between genes downregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and treatment with 3 µM of the pinometostat-related compound EPZ004777 for 6 days . p-Value computed by two-tailed Fisher Exact test. ( D ) Bar plot depicting upregulated genes with the highest fold changes from RNA-seq analysis of three independent experiments of DMSO- (blue) or pinometostat-treated (red) MV4;11 cells with uncertainty presented as the standard deviation computed by CuffDiff with immune response genes outlined in gray. ( E ) RT-qPCR analysis showing the fold-change for HLA-DRA, HLA-DRB1 , and CIITA gene expression in MV4;11 cells ± 100 nM pinometostat treatment for 7 days. Results are shown as mean ± S.E.M. of three independent experiments. Student’s t-test (*****p ≤ 0.00001). ( F ) Bar plot depicting the top pinometostat-downregulated genes from the RNA-seq analysis that are previously described MLL-AF4 targets including the oncogenes MEF2C, FLT3 , and PBX3 . ( G ) RT-qPCR analysis of MEF2C, FLT3 , and PBX3 expression in MV4;11 cells ± with 100 nM pinometostat for 7 days. Results are displayed as mean fold-change ± S.E.M. of three independent experiments; Student’s t-test (**** p ≤ 0.0001). ( H ) Western blot for FLT3 with RBBP5 as loading control in MV4;11 cells treated with 100 nM pinometostat for 5 or 7 days. ( I ) Venn diagram displaying the overlap between genes upregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and genes downregulated in leukemic cells from patients with FLT3-ITD vs normal FLT3 karyotypically normal AML . p-Value computed by two-tailed Fisher Exact test.

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Expressing, Two Tailed Test, RNA Sequencing Assay, Standard Deviation, Quantitative RT-PCR, Western Blot

    ( A ) Gene Ontology analysis (DAVID) ( ; ) of pinometostat-upregulated genes showing top functional classification categories and the number of genes in each category that are significantly upregulated. ( B ) Bar graph of Cuffdiff output for the expression of INFG (IFN-γ) from RNA-seq in MV4;11 cells ± 100 nM pinometostat. Values are represented as FPKM + 1 for three independent experiments with standard deviation. Student’s t-test (ns p > 0.05). ( C ) Bar graph of Cuffdiff output for the expression of ITGAM (CD11b), ITGAX (CD11c) , and CD86 macrophage cell surface marker expression in MV4;11 cells ± 100 nM pinometostat for 7 days. Values are represented as FPKM + 1 for three independent experiments with standard deviation. Student’s t-test (** p < 0.01, *** p ≤ 0.001). ( D ) GSEA ( ; ) of the set of differentially expressed genes in MV4;11 cells ± 100 nM pinometostat compared to KEGG_HEMATOPOIETIC_CELL_LINEAGE and IVANOVA_HEMATOPOIESIS_CELL_LINEAGE gene sets from the MSigDB data base. NES - normalized enrichment score. ( E ) RT-qPCR analysis of CSF3R and CSF1R expression in MV4;11 cells ± 100 nM pinometostat for 7 days. Results are displayed as mean fold-change vs. DMSO-treated cells ± S.E.M. of three independent experiments. Student’s t-test (** p < 0.01, *** p ≤ 0.001). ( F ) Venn diagram displaying the overlap between genes downregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and genes upregulated in leukemic cells from patients with FLT3-ITD vs normal FLT3 karyotypically normal AML . p-Value computed by two-tailed Fisher Exact test.

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet: ( A ) Gene Ontology analysis (DAVID) ( ; ) of pinometostat-upregulated genes showing top functional classification categories and the number of genes in each category that are significantly upregulated. ( B ) Bar graph of Cuffdiff output for the expression of INFG (IFN-γ) from RNA-seq in MV4;11 cells ± 100 nM pinometostat. Values are represented as FPKM + 1 for three independent experiments with standard deviation. Student’s t-test (ns p > 0.05). ( C ) Bar graph of Cuffdiff output for the expression of ITGAM (CD11b), ITGAX (CD11c) , and CD86 macrophage cell surface marker expression in MV4;11 cells ± 100 nM pinometostat for 7 days. Values are represented as FPKM + 1 for three independent experiments with standard deviation. Student’s t-test (** p < 0.01, *** p ≤ 0.001). ( D ) GSEA ( ; ) of the set of differentially expressed genes in MV4;11 cells ± 100 nM pinometostat compared to KEGG_HEMATOPOIETIC_CELL_LINEAGE and IVANOVA_HEMATOPOIESIS_CELL_LINEAGE gene sets from the MSigDB data base. NES - normalized enrichment score. ( E ) RT-qPCR analysis of CSF3R and CSF1R expression in MV4;11 cells ± 100 nM pinometostat for 7 days. Results are displayed as mean fold-change vs. DMSO-treated cells ± S.E.M. of three independent experiments. Student’s t-test (** p < 0.01, *** p ≤ 0.001). ( F ) Venn diagram displaying the overlap between genes downregulated in MV4;11 cells by 100 nM pinometostat treatment (7 days) and genes upregulated in leukemic cells from patients with FLT3-ITD vs normal FLT3 karyotypically normal AML . p-Value computed by two-tailed Fisher Exact test.

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Functional Assay, Expressing, RNA Sequencing Assay, Standard Deviation, Marker, Quantitative RT-PCR, Two Tailed Test

    ( A ) Scatterplot of the mean normalized log 2- FPKM (three independent replicates) of genes expressed in DMSO-treated MV4;11 cells plotted versus the log 2- HMD (H3K79me2) for +1000 bp from the TSS. Colors signify: red, MLL-AF4 targets ; purple, MLL-AF4 targets downregulated by 100 nM pinometostat. ( B ) (top) Quantitative measurement of H3K79me2 modification density from ICeChIP-seq of MV4;11 cells treated with 100 nM pinometostat for 7 days contoured over the promoters (−2 to +two kp from the TSS) of indicated gene sets, including genes up- or down-regulated by 100 nM pinometostat, the most highly-expressed genes, MLL-AF4 target genes as well as those MLL-AF4 targets downregulated by 100 nM pinometostat. (bottom) Heatmaps depicting H3K79me2 density (HMD) for the gene promoter regions shown above ranked by HMD. ( C ) Scatterplot of genes in MV4;11 cells downregulated by 100 nM pinometostat depicting log 2 -fold change H3K79me2 HMD (+1000 bp from TSS) versus the log 2 -fold change of the mean normalized FPKM (three independent replicates) for 100 nM pinometostat or DMSO treated cells. Colors signify: red, MLL-AF4 targets ; orange, FLT3-ITD upregulated genes ; blue, FLT3-ITD downregulated genes ; yellow, labeled genes in gray font. ( D ) H3K79me2 meta promoter profiles as in B , but including curves for 100 nM pinometostat treatment at 4 days, and the promoter set where this complex spreads . ( E ) The FLT3 locus as representative of an MLL-AF4 target ( ; ) downregulated by 100 nM pinometostat, displaying MV4;11 ICeChIP-seq tracks for H3K79me2 100 nM pinometostat 4- and 7-day treatment and H3K27me3 and H3K4me3 tracks from 100 nM pinometostat 7-day treatment as well as DMSO control-treated cells and an RNA-seq track (FPKM) from a single replicate of 100 nM pinometostat 7-day treatment and DMSO-treated cells.

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet: ( A ) Scatterplot of the mean normalized log 2- FPKM (three independent replicates) of genes expressed in DMSO-treated MV4;11 cells plotted versus the log 2- HMD (H3K79me2) for +1000 bp from the TSS. Colors signify: red, MLL-AF4 targets ; purple, MLL-AF4 targets downregulated by 100 nM pinometostat. ( B ) (top) Quantitative measurement of H3K79me2 modification density from ICeChIP-seq of MV4;11 cells treated with 100 nM pinometostat for 7 days contoured over the promoters (−2 to +two kp from the TSS) of indicated gene sets, including genes up- or down-regulated by 100 nM pinometostat, the most highly-expressed genes, MLL-AF4 target genes as well as those MLL-AF4 targets downregulated by 100 nM pinometostat. (bottom) Heatmaps depicting H3K79me2 density (HMD) for the gene promoter regions shown above ranked by HMD. ( C ) Scatterplot of genes in MV4;11 cells downregulated by 100 nM pinometostat depicting log 2 -fold change H3K79me2 HMD (+1000 bp from TSS) versus the log 2 -fold change of the mean normalized FPKM (three independent replicates) for 100 nM pinometostat or DMSO treated cells. Colors signify: red, MLL-AF4 targets ; orange, FLT3-ITD upregulated genes ; blue, FLT3-ITD downregulated genes ; yellow, labeled genes in gray font. ( D ) H3K79me2 meta promoter profiles as in B , but including curves for 100 nM pinometostat treatment at 4 days, and the promoter set where this complex spreads . ( E ) The FLT3 locus as representative of an MLL-AF4 target ( ; ) downregulated by 100 nM pinometostat, displaying MV4;11 ICeChIP-seq tracks for H3K79me2 100 nM pinometostat 4- and 7-day treatment and H3K27me3 and H3K4me3 tracks from 100 nM pinometostat 7-day treatment as well as DMSO control-treated cells and an RNA-seq track (FPKM) from a single replicate of 100 nM pinometostat 7-day treatment and DMSO-treated cells.

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Modification, Labeling, RNA Sequencing Assay

    ( A ) Plots of H3K79me2 density from ICeChIP-seq in MV4;11 cells treated with 100 nM pinometostat for 4 or 7 days. H3K79me2 modification density (HMD) is displayed from ± 2000 bp of the TSS of all genes expressed, non-MLL-AF4 targets downregulated by 100 nM pinometostat and MLL-AF4 targets not downregulated by 100 nM pinometostat. ( B ) Scatterplot of genes downregulated by 100 nM pinometostat plotted as the log 2 fold-change in gene expression vs the log 2 fold-change in HMD with MLL-AF4 targets in red, FLT3-ITD upregulated genes in orange, FLT3-ITD downregulated genes in cyan and labeled genes highlighted in yellow. Regression analysis of all genes (R 2 = 0.13) or the MLL-AF4 target subset (R 2 = 0.20) reveals poor correlation between the fold changes of H3K79me2 and RNA expression. ( C ) Scatterplot showing the reproducibility of H3K79me2 HMD from 0 to +2000 bp from the TSS from ICeChIP of (left) immunoprecipitation replicates performed simultaneously in MV4;11 cells treated with DMSO for 4 days; (Right) immunoprecipitation performed by different individuals on separate occasions from MV4;11 cells treated with DMSO for 4 or 7 days. ( D ) H3K79me2 HMD of ICeChIP replicates from MV4;11 cells ± 100 nM pinometostat from ± 2000 bp of the TSS of the gene groups identified, for comparison to replicate one presented in . ( E ) Scatterplots demonstrating the linearity of H3K79me2 calibrant immunoprecipitation from denaturative ICeChIP-seq from MV4;11 cells treated with 0 or 100 nM pinometostat for 7 days for replicate 1. Similar scatter plots for treated and untreated 7 day points for native ICeChIP of H3K4me3 and H3K27me3 ICeChIP are displayed.

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet: ( A ) Plots of H3K79me2 density from ICeChIP-seq in MV4;11 cells treated with 100 nM pinometostat for 4 or 7 days. H3K79me2 modification density (HMD) is displayed from ± 2000 bp of the TSS of all genes expressed, non-MLL-AF4 targets downregulated by 100 nM pinometostat and MLL-AF4 targets not downregulated by 100 nM pinometostat. ( B ) Scatterplot of genes downregulated by 100 nM pinometostat plotted as the log 2 fold-change in gene expression vs the log 2 fold-change in HMD with MLL-AF4 targets in red, FLT3-ITD upregulated genes in orange, FLT3-ITD downregulated genes in cyan and labeled genes highlighted in yellow. Regression analysis of all genes (R 2 = 0.13) or the MLL-AF4 target subset (R 2 = 0.20) reveals poor correlation between the fold changes of H3K79me2 and RNA expression. ( C ) Scatterplot showing the reproducibility of H3K79me2 HMD from 0 to +2000 bp from the TSS from ICeChIP of (left) immunoprecipitation replicates performed simultaneously in MV4;11 cells treated with DMSO for 4 days; (Right) immunoprecipitation performed by different individuals on separate occasions from MV4;11 cells treated with DMSO for 4 or 7 days. ( D ) H3K79me2 HMD of ICeChIP replicates from MV4;11 cells ± 100 nM pinometostat from ± 2000 bp of the TSS of the gene groups identified, for comparison to replicate one presented in . ( E ) Scatterplots demonstrating the linearity of H3K79me2 calibrant immunoprecipitation from denaturative ICeChIP-seq from MV4;11 cells treated with 0 or 100 nM pinometostat for 7 days for replicate 1. Similar scatter plots for treated and untreated 7 day points for native ICeChIP of H3K4me3 and H3K27me3 ICeChIP are displayed.

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Modification, Expressing, Labeling, RNA Expression, Immunoprecipitation

    ( A ) MLL-rearranged leukemia lines with genotypes indicated were treated with 100 nM pinometostat (left panel, DOT1L inhibitor) or 30 nM tandutinib (right panel, FLT3 inhibitor MLN518), and relative growth monitored by CellTiter Glo 2.0 assay on the indicated days. Relative viability presented is the mean fraction of luminescence of treated versus side-by-side mock treated cultures (same volume of DMSO) for three independent replicates ± S.E.M. Student’s t-test (** p ≤ 0.01, *** p ≤ 0.001). ( B ) Western blots of phosphorylated STAT5 (active) or total STAT5A with H3 or HNRNPK as loading controls across the cell lines from panel A treated as indicated; H3K79me2 is monitored in pinometostat-treated lines to confirm inhibition. ( C ) Time course of gene expression by RT-qPCR, presented as mean fold-change of FLT3, PBX3, PIM1 , and MEF2C in MV4;11 cells ± 100 nM pinometostat at each time point indicated ± S.E.M.; n = 3; Student’s t-test (ns p > 0.05, * p ≤ 0.05, **** p ≤ 0.0001, ***** p < 0.00001). ( D-E ) DOT1L and FLT3 inhibition downregulate STAT5A targets in FLT3-ITD . RT-qPCR expression analysis presented as mean fold-change ± S.E.M. for the indicated transcript in MV4;11 cells treated with indicated inhibitor versus mock-treatment for 7 days. Student’s t-test (** p < 0.01, **** p < 0.0001, ***** p < 0.00001). ( F ) Proliferation assay as in panel A, with three clonal populations of MV4;11 cells virally transduced, selected, then induced to express shRNA to FLT3 or a scrambled shRNA control by 1 µg/mL doxycycline. Means of fractional viability relative to uninduced cells ± S.E.M. are shown for three independent experiments; Student’s t-test (** p < 0.01). ( G ) RT-qPCR analysis of PIM1, PIM2 , and ARID3B expression in MV4;11 cells expressing an inducible shRNA targeting FLT3 for 7 days. Results are depicted as fold-change expression of control cells expressing shRNA to GFP . ( H ) Proliferation assay of K562, PL-21, and EOL-1 cells treated with 10 µM or 100 nM pinometostat using CellTiter Glo 2.0 to measure viability, showing the luminescence fraction of inhibited over DMSO-treated cells. Means ± SE are shown for three independent experiments. Student’s t-test of day 7 (EOL-1 cells), day 9 (PL-21), or days 9 and 11 (K562 and PL-21) values: ns p > 0.05, * p < 0.05, **** p < 0.0001. ( I ) Gene expression analysis by RT-qPCR in PL-21 cells treated for 9 days with 10 µM pinometostat. Results are displayed as fold-change over DMSO-treated cells with means ± SE for three independent experiments (ND = not detected). Student’s t-test (**** p < 0.0001). ( J ) Western blots of (left) cell extract from PL-21 cells treated with 10 µM pinometostat for 9 days and (right) EOL-1 cells treated with 100 nM pinometostat for 7 days and then blotted for H3K79me2 and p-STAT5 with H2B or HNRNPK as a loading controls. ( K ) Gene expression analysis by RT-qPCR in EOL-1 cells treated for 7 days with 100 nM or 10 µM pinometostat. Results are displayed as fold-change over DMSO-treated cells with means ± SE for three independent experiments. Student’s t-test (ns p > 0.05, **** p < 0.0001).

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet: ( A ) MLL-rearranged leukemia lines with genotypes indicated were treated with 100 nM pinometostat (left panel, DOT1L inhibitor) or 30 nM tandutinib (right panel, FLT3 inhibitor MLN518), and relative growth monitored by CellTiter Glo 2.0 assay on the indicated days. Relative viability presented is the mean fraction of luminescence of treated versus side-by-side mock treated cultures (same volume of DMSO) for three independent replicates ± S.E.M. Student’s t-test (** p ≤ 0.01, *** p ≤ 0.001). ( B ) Western blots of phosphorylated STAT5 (active) or total STAT5A with H3 or HNRNPK as loading controls across the cell lines from panel A treated as indicated; H3K79me2 is monitored in pinometostat-treated lines to confirm inhibition. ( C ) Time course of gene expression by RT-qPCR, presented as mean fold-change of FLT3, PBX3, PIM1 , and MEF2C in MV4;11 cells ± 100 nM pinometostat at each time point indicated ± S.E.M.; n = 3; Student’s t-test (ns p > 0.05, * p ≤ 0.05, **** p ≤ 0.0001, ***** p < 0.00001). ( D-E ) DOT1L and FLT3 inhibition downregulate STAT5A targets in FLT3-ITD . RT-qPCR expression analysis presented as mean fold-change ± S.E.M. for the indicated transcript in MV4;11 cells treated with indicated inhibitor versus mock-treatment for 7 days. Student’s t-test (** p < 0.01, **** p < 0.0001, ***** p < 0.00001). ( F ) Proliferation assay as in panel A, with three clonal populations of MV4;11 cells virally transduced, selected, then induced to express shRNA to FLT3 or a scrambled shRNA control by 1 µg/mL doxycycline. Means of fractional viability relative to uninduced cells ± S.E.M. are shown for three independent experiments; Student’s t-test (** p < 0.01). ( G ) RT-qPCR analysis of PIM1, PIM2 , and ARID3B expression in MV4;11 cells expressing an inducible shRNA targeting FLT3 for 7 days. Results are depicted as fold-change expression of control cells expressing shRNA to GFP . ( H ) Proliferation assay of K562, PL-21, and EOL-1 cells treated with 10 µM or 100 nM pinometostat using CellTiter Glo 2.0 to measure viability, showing the luminescence fraction of inhibited over DMSO-treated cells. Means ± SE are shown for three independent experiments. Student’s t-test of day 7 (EOL-1 cells), day 9 (PL-21), or days 9 and 11 (K562 and PL-21) values: ns p > 0.05, * p < 0.05, **** p < 0.0001. ( I ) Gene expression analysis by RT-qPCR in PL-21 cells treated for 9 days with 10 µM pinometostat. Results are displayed as fold-change over DMSO-treated cells with means ± SE for three independent experiments (ND = not detected). Student’s t-test (**** p < 0.0001). ( J ) Western blots of (left) cell extract from PL-21 cells treated with 10 µM pinometostat for 9 days and (right) EOL-1 cells treated with 100 nM pinometostat for 7 days and then blotted for H3K79me2 and p-STAT5 with H2B or HNRNPK as a loading controls. ( K ) Gene expression analysis by RT-qPCR in EOL-1 cells treated for 7 days with 100 nM or 10 µM pinometostat. Results are displayed as fold-change over DMSO-treated cells with means ± SE for three independent experiments. Student’s t-test (ns p > 0.05, **** p < 0.0001).

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Western Blot, Inhibition, Expressing, Quantitative RT-PCR, Proliferation Assay, shRNA

    ( A ) RT-qPCR analysis of HOXA9 and MEIS1 expression from three independent experiments of MOLM13 cells treated with 100 nM pinometostat for 7 days. Fold change over DMSO-treated cells is depicted ± S.E.M. Student’s t-test (ns p > 0.05). ( B ) (left) RT-qPCR analysis of FLT3 and PIM1 expression in MV4;11 cells ± 50 nM SGC0946 for 7 days. Results are displayed as mean fold-change vs. DMSO-treated cells ± S.E.M. of three independent experiments. Student’s t-test (* p < 0.05, *** p ≤ 0.001). (right) Western blots from MV4;11 cells (left) treated with 50 nM SGC0946 for 7 days blotted for phosphorylated STAT5, H3K79me2, or histone H2B as a loading control. (right) MV4;11 cells treated with increasing concentrations of SGC0946 for 7 days blotted for H3K79me2 or H2B as a loading control. ( C ) Quantitative western blot of whole cell extracts from 3 experiments of MV4;11 cells ± 100 nM pinometostat for 7 days, stained with antibodies for phosphorylated STAT5 or histone H3 as a loading control. The blot includes a dilution series of the extract from the DMSO-treated sample one that encompasses the range of signal observed in each of the replicates and is used to calibrate a relative quantification of phosphorylated STAT5A signal integrated in ImageJ and shown in the bar graph at right as a 65 ± 8% reduction of the DMSO treated samples ± SD. Student’s t-test (** p < 0.01). ( D ) Gene Set Enrichment Analysis (GSEA) ( ; ) of the set of downregulated genes in MV4;11 cells ± 100 nM pinometostat compared to genes upregulated by exogenous expression of constitutively active STAT5A in the WIERENGA_STAT5A_TARGETS GROUP1 gene set from the MSigDB database. ( E ) Bar graph of Cuffdiff output for the expression of STAT5A targets ARID3B , PIM1 , and PIM2 from RNA-seq in MV4;11 cells ± 100 nM pinometostat. Values are represented as log(10) FPKM + 1 for three independent experiments with standard deviation. Student’s t-test (** p < 0.01, *** p < 0.001). ( F ) RT-qPCR analysis of PBX3 , PIM1, FLT3 , and MEF2C expression from three independent experiments of MOLM13 cells treated with 100 nM pinometostat for 7 days. Fold change over DMSO-treated cells is depicted ± S.E.M. Student’s t-test (ns p > 0.05, *** p < 0.001, **** p < 0.0001). ( G ) Proliferation assay of MV4;11 cells treated with DOT1L or FLT3 inhibitors alone or in combination using CellTiter Glo 2.0 to measure viability, showing the luminescence fraction of inhibited over uninhibited cells. Data are represented as mean ± SE of three independent experiments. Student’s t-test for significance of day 7 values: 100 nM pinometostat vs. combined ** p < 0.01, 30 nM tandutinib vs combined *** p < 0.001. ( H ) Same as G but cells were treated with DOT1L and PIM1 inhibitors alone or in combination. Student’s t-test of day 7 values: 100 nM pinometostat vs. combined * p < 0.05, 10 µM quercetagenin vs combined ** p < 0.01. Purple asterisks indicate Student’s t-test for significance of day 5 for 100 nM pinometostat vs. combination treatment ** p < 0.01. ( I ) Western blots of MV4;11 cell extract from clonal cell lines expressing shRNA to FLT3 (clone 3) or GFP blotted for phosphorylated STAT5 or histone H3 as a loading control. ( J ) Western blots of cell extract from MV4;11 cells treated with 100 nM pinometostat for the indicated number of days and then blotted for H3K79me2 and HNRNPK as a loading control.

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet: ( A ) RT-qPCR analysis of HOXA9 and MEIS1 expression from three independent experiments of MOLM13 cells treated with 100 nM pinometostat for 7 days. Fold change over DMSO-treated cells is depicted ± S.E.M. Student’s t-test (ns p > 0.05). ( B ) (left) RT-qPCR analysis of FLT3 and PIM1 expression in MV4;11 cells ± 50 nM SGC0946 for 7 days. Results are displayed as mean fold-change vs. DMSO-treated cells ± S.E.M. of three independent experiments. Student’s t-test (* p < 0.05, *** p ≤ 0.001). (right) Western blots from MV4;11 cells (left) treated with 50 nM SGC0946 for 7 days blotted for phosphorylated STAT5, H3K79me2, or histone H2B as a loading control. (right) MV4;11 cells treated with increasing concentrations of SGC0946 for 7 days blotted for H3K79me2 or H2B as a loading control. ( C ) Quantitative western blot of whole cell extracts from 3 experiments of MV4;11 cells ± 100 nM pinometostat for 7 days, stained with antibodies for phosphorylated STAT5 or histone H3 as a loading control. The blot includes a dilution series of the extract from the DMSO-treated sample one that encompasses the range of signal observed in each of the replicates and is used to calibrate a relative quantification of phosphorylated STAT5A signal integrated in ImageJ and shown in the bar graph at right as a 65 ± 8% reduction of the DMSO treated samples ± SD. Student’s t-test (** p < 0.01). ( D ) Gene Set Enrichment Analysis (GSEA) ( ; ) of the set of downregulated genes in MV4;11 cells ± 100 nM pinometostat compared to genes upregulated by exogenous expression of constitutively active STAT5A in the WIERENGA_STAT5A_TARGETS GROUP1 gene set from the MSigDB database. ( E ) Bar graph of Cuffdiff output for the expression of STAT5A targets ARID3B , PIM1 , and PIM2 from RNA-seq in MV4;11 cells ± 100 nM pinometostat. Values are represented as log(10) FPKM + 1 for three independent experiments with standard deviation. Student’s t-test (** p < 0.01, *** p < 0.001). ( F ) RT-qPCR analysis of PBX3 , PIM1, FLT3 , and MEF2C expression from three independent experiments of MOLM13 cells treated with 100 nM pinometostat for 7 days. Fold change over DMSO-treated cells is depicted ± S.E.M. Student’s t-test (ns p > 0.05, *** p < 0.001, **** p < 0.0001). ( G ) Proliferation assay of MV4;11 cells treated with DOT1L or FLT3 inhibitors alone or in combination using CellTiter Glo 2.0 to measure viability, showing the luminescence fraction of inhibited over uninhibited cells. Data are represented as mean ± SE of three independent experiments. Student’s t-test for significance of day 7 values: 100 nM pinometostat vs. combined ** p < 0.01, 30 nM tandutinib vs combined *** p < 0.001. ( H ) Same as G but cells were treated with DOT1L and PIM1 inhibitors alone or in combination. Student’s t-test of day 7 values: 100 nM pinometostat vs. combined * p < 0.05, 10 µM quercetagenin vs combined ** p < 0.01. Purple asterisks indicate Student’s t-test for significance of day 5 for 100 nM pinometostat vs. combination treatment ** p < 0.01. ( I ) Western blots of MV4;11 cell extract from clonal cell lines expressing shRNA to FLT3 (clone 3) or GFP blotted for phosphorylated STAT5 or histone H3 as a loading control. ( J ) Western blots of cell extract from MV4;11 cells treated with 100 nM pinometostat for the indicated number of days and then blotted for H3K79me2 and HNRNPK as a loading control.

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Quantitative RT-PCR, Expressing, Western Blot, Staining, RNA Sequencing Assay, Standard Deviation, Proliferation Assay, shRNA

    ( A ) Western blots of whole cell extract from MV4;11 cells treated with 100 nM pinometostat for 7 days and blotted for H3K4me3 or LEDGF as a loading control. ( B ) Western blots of whole cell extract from MV4;11 cells treated with MLL1 inhibitors MI-503 (250 nM) or MM-401 (10 µM) or DMSO for 7 days and blotted for histone H3 lysine four trimethylation (H3K4me3) or GAPDH as a loading control. ( C ) Western blots of MV4;11 cell extract treated with MLL1 inhibitors MI-503 (250 nM) or MM-401 (10 µM) for 7 days and blotted for phosphorylated STAT5, histone H3 lysine 79 dimethylation (H3K79me2) or GAPDH as a loading control. ( D ) H3K79me2 meta promoter profiles ± 2000 bp of the TSS as in , representing 4 days, rather than seven days of 100 nM pinometostat treatment versus DMSO control. ( E ) ICe-ChIP-qPCR analysis of the percent H3K4me3 at the promoters of several genes both upregulated (BCL6, CSF3R, HLA-DRA) and downregulated (MEF2C, PIM1, ARID3B, and FLT3) by pinometostat as well as MLL-AF4 targets (HOXA9 and MEIS1) and an intergenic region (with little change) from two experiments as well as ICe-ChIP-seq (hashed lines) in MV4;11 cells ± 100 nM pinometostat for 7 days. Note that ICeChIP qPCR values are often slightly inflated as due to the capture of dinucleosomes that are over-represented due to avidity bias that are normally filtered out in ICeChIP. ( F ) MV4;11 cells were treated with DOT1L or MLL1 inhibitors alone or in combination for 7 days. Viability was analyzed using CellTiter Glo 2.0, showing the luminescence fraction of inhibited over DMSO-treated cells. Means ± SE are shown for three independent experiments. Student’s t-test of day 7 values: 100 nM pinometostat vs. 100 nM pinometostat + 250 nM MI-503 ** p < 0.01 100 nM pinometostat vs. 100 nM pinometostat + 10 µM MM-401 * p < 0.05. ( G ) Model of MLL-fusion-mediated activation of HOXA9/MEIS1 and STAT5A co-targets in MLL-r, FLT3-ITD+ leukemia. MLL-AF4 activates HOXA9 , MEIS1 , and FLT3-ITD gene expression through recruitment of DOT1L and H3K79me2 hypermethylation (fuchsia). FLT3-ITD phosphorylates STAT5A allowing it to translocate to the nucleus to cooperatively bind HOXA9/MEIS1 targets with PBX3 and facilitate gene activation. ( H ) Scatterplot from ICeChIP-seq of MV4;11 cells ± 100 nM pinometostat of the log 2 (fold-change HMD of H3K79me2 vs. H3K4me3) of all expressed genes showing MLL-AF4 targets (red) and MLL-AF4 targets downregulated by pinometostat (purple). ( I ) The average fold-change in H3K4me3 HMD from ICeChIP-seq of MV4;11 cells ± 100 nM pinometostat at expressed genes in 20 bins grouped by decreasing expression (bin 1–20 sorted by highest to lowest FPKM of DMSO-treated cells).

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet: ( A ) Western blots of whole cell extract from MV4;11 cells treated with 100 nM pinometostat for 7 days and blotted for H3K4me3 or LEDGF as a loading control. ( B ) Western blots of whole cell extract from MV4;11 cells treated with MLL1 inhibitors MI-503 (250 nM) or MM-401 (10 µM) or DMSO for 7 days and blotted for histone H3 lysine four trimethylation (H3K4me3) or GAPDH as a loading control. ( C ) Western blots of MV4;11 cell extract treated with MLL1 inhibitors MI-503 (250 nM) or MM-401 (10 µM) for 7 days and blotted for phosphorylated STAT5, histone H3 lysine 79 dimethylation (H3K79me2) or GAPDH as a loading control. ( D ) H3K79me2 meta promoter profiles ± 2000 bp of the TSS as in , representing 4 days, rather than seven days of 100 nM pinometostat treatment versus DMSO control. ( E ) ICe-ChIP-qPCR analysis of the percent H3K4me3 at the promoters of several genes both upregulated (BCL6, CSF3R, HLA-DRA) and downregulated (MEF2C, PIM1, ARID3B, and FLT3) by pinometostat as well as MLL-AF4 targets (HOXA9 and MEIS1) and an intergenic region (with little change) from two experiments as well as ICe-ChIP-seq (hashed lines) in MV4;11 cells ± 100 nM pinometostat for 7 days. Note that ICeChIP qPCR values are often slightly inflated as due to the capture of dinucleosomes that are over-represented due to avidity bias that are normally filtered out in ICeChIP. ( F ) MV4;11 cells were treated with DOT1L or MLL1 inhibitors alone or in combination for 7 days. Viability was analyzed using CellTiter Glo 2.0, showing the luminescence fraction of inhibited over DMSO-treated cells. Means ± SE are shown for three independent experiments. Student’s t-test of day 7 values: 100 nM pinometostat vs. 100 nM pinometostat + 250 nM MI-503 ** p < 0.01 100 nM pinometostat vs. 100 nM pinometostat + 10 µM MM-401 * p < 0.05. ( G ) Model of MLL-fusion-mediated activation of HOXA9/MEIS1 and STAT5A co-targets in MLL-r, FLT3-ITD+ leukemia. MLL-AF4 activates HOXA9 , MEIS1 , and FLT3-ITD gene expression through recruitment of DOT1L and H3K79me2 hypermethylation (fuchsia). FLT3-ITD phosphorylates STAT5A allowing it to translocate to the nucleus to cooperatively bind HOXA9/MEIS1 targets with PBX3 and facilitate gene activation. ( H ) Scatterplot from ICeChIP-seq of MV4;11 cells ± 100 nM pinometostat of the log 2 (fold-change HMD of H3K79me2 vs. H3K4me3) of all expressed genes showing MLL-AF4 targets (red) and MLL-AF4 targets downregulated by pinometostat (purple). ( I ) The average fold-change in H3K4me3 HMD from ICeChIP-seq of MV4;11 cells ± 100 nM pinometostat at expressed genes in 20 bins grouped by decreasing expression (bin 1–20 sorted by highest to lowest FPKM of DMSO-treated cells).

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Western Blot, ChIP-sequencing, Activation Assay, Expressing

    Journal: eLife

    Article Title: Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

    doi: 10.7554/eLife.64960

    Figure Lengend Snippet:

    Article Snippet: antibody , anti-FLT3 (Rabbit polyclonal) , Cell Signaling , Cat. #: 33462S , WB (1:500).

    Techniques: Recombinant, Plasmid Preparation, Construct, cDNA Library Assay, RNA Extraction, SYBR Green Assay, Proliferation Assay, Software, Sequencing, shRNA

    Bacterial strains and plasmids

    Journal:

    Article Title: Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae

    doi:

    Figure Lengend Snippet: Bacterial strains and plasmids

    Article Snippet: The mean number of CFU (± standard deviations) was determined for each time point, and the Student-Newman-Keuls comparison of means ( P < 0.05) was used to determine statistical significance. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3 caption a7 Coculture of Acanthomoebae with strains of Legionella . (A) Amoeba liquid cocultures were set up in saline with approximately 10 4 amoebae/ml and 10 3 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml.

    Techniques: Plasmid Preparation, Mutagenesis, Clone Assay, Generated, Sequencing

    Amino acid comparison of the Mip proteins of L. longbeachae serogroup 1 ATCC 33462 (L.1), L. longbeachae serogroup 1 A5H5 (A5H5), L. longbeachae serogroup 2 ATCC 33484 (L.2), L. pneumophila serogroup 1 (L. PNEUM. 1), and L. micdadei (L. MIC.). Asterisks indicate amino acids identical to those of L. longbeachae; triangles indicate amino acids predicted to form part of the active site for PPIase activity of Mip. The arrow indicates the site of signal peptidase cleavage.

    Journal:

    Article Title: Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae

    doi:

    Figure Lengend Snippet: Amino acid comparison of the Mip proteins of L. longbeachae serogroup 1 ATCC 33462 (L.1), L. longbeachae serogroup 1 A5H5 (A5H5), L. longbeachae serogroup 2 ATCC 33484 (L.2), L. pneumophila serogroup 1 (L. PNEUM. 1), and L. micdadei (L. MIC.). Asterisks indicate amino acids identical to those of L. longbeachae; triangles indicate amino acids predicted to form part of the active site for PPIase activity of Mip. The arrow indicates the site of signal peptidase cleavage.

    Article Snippet: The mean number of CFU (± standard deviations) was determined for each time point, and the Student-Newman-Keuls comparison of means ( P < 0.05) was used to determine statistical significance. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3 caption a7 Coculture of Acanthomoebae with strains of Legionella . (A) Amoeba liquid cocultures were set up in saline with approximately 10 4 amoebae/ml and 10 3 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml.

    Techniques: Activity Assay

    (A) Line diagram depicts the DNA sequence determined from sequencing pIMVS27. The solid box shows the mip gene from L. longbeachae serogroup 1 ATCC 33462, selected restriction sites in the mip gene, and the stem loop structure at the end of the ORF. The inset sequence is the DNA sequence upstream of the ATG start site for translation in L. longbeachae serogroup 1 and L. pneumophila serogroup 1, showing the −10 and −35 promoter regions determined by primer extension analysis. The shaded box indicates the −35 promoter region proposed for L. longbeachae. The nonshaded box is the −35 region proposed in reference 16. The start site for transcription is shown with a solid arrow. (B) Southern hybridization demonstrating mutagenesis by allelic exchange of the L. longbeachae serogroup 1 mip gene. DNA was digested with KpnI and probed with DIG-labeled pIMVS27. Lanes: a, L. longbeachae serogroup 1 A5H5; b, B8. The solid arrow indicates the 7.3-kb fragment generated in B8 due to the loss of an internal KpnI site which generates 1- and 7-kb fragments in the parent strain. A similar pattern was observed for L. longbeachae serogroup 1 ATCC 33462 (data not shown).

    Journal:

    Article Title: Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae

    doi:

    Figure Lengend Snippet: (A) Line diagram depicts the DNA sequence determined from sequencing pIMVS27. The solid box shows the mip gene from L. longbeachae serogroup 1 ATCC 33462, selected restriction sites in the mip gene, and the stem loop structure at the end of the ORF. The inset sequence is the DNA sequence upstream of the ATG start site for translation in L. longbeachae serogroup 1 and L. pneumophila serogroup 1, showing the −10 and −35 promoter regions determined by primer extension analysis. The shaded box indicates the −35 promoter region proposed for L. longbeachae. The nonshaded box is the −35 region proposed in reference 16. The start site for transcription is shown with a solid arrow. (B) Southern hybridization demonstrating mutagenesis by allelic exchange of the L. longbeachae serogroup 1 mip gene. DNA was digested with KpnI and probed with DIG-labeled pIMVS27. Lanes: a, L. longbeachae serogroup 1 A5H5; b, B8. The solid arrow indicates the 7.3-kb fragment generated in B8 due to the loss of an internal KpnI site which generates 1- and 7-kb fragments in the parent strain. A similar pattern was observed for L. longbeachae serogroup 1 ATCC 33462 (data not shown).

    Article Snippet: The mean number of CFU (± standard deviations) was determined for each time point, and the Student-Newman-Keuls comparison of means ( P < 0.05) was used to determine statistical significance. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3 caption a7 Coculture of Acanthomoebae with strains of Legionella . (A) Amoeba liquid cocultures were set up in saline with approximately 10 4 amoebae/ml and 10 3 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml.

    Techniques: Sequencing, Hybridization, Mutagenesis, Labeling, Generated

    Coculture of Acanthomoebae with strains of Legionella. (A) Amoeba liquid cocultures were set up in saline with approximately 104 amoebae/ml and 103 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml. Samples were taken at various time intervals, and the number of Legionella organisms was determined by plating on selective media. Each time point represents the mean number of CFU recovered, and the vertical bars indicate standard deviations. (B) Amoebae were cocultured in an artificial potting mix system with strains of Legionella as indicated above. Numbers of viable Legionella organisms were determined at various time points by treatment of the soil sample with acid and plating on selective media. The experiments shown are representative of two independent experiments.

    Journal:

    Article Title: Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae

    doi:

    Figure Lengend Snippet: Coculture of Acanthomoebae with strains of Legionella. (A) Amoeba liquid cocultures were set up in saline with approximately 104 amoebae/ml and 103 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml. Samples were taken at various time intervals, and the number of Legionella organisms was determined by plating on selective media. Each time point represents the mean number of CFU recovered, and the vertical bars indicate standard deviations. (B) Amoebae were cocultured in an artificial potting mix system with strains of Legionella as indicated above. Numbers of viable Legionella organisms were determined at various time points by treatment of the soil sample with acid and plating on selective media. The experiments shown are representative of two independent experiments.

    Article Snippet: The mean number of CFU (± standard deviations) was determined for each time point, and the Student-Newman-Keuls comparison of means ( P < 0.05) was used to determine statistical significance. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3 caption a7 Coculture of Acanthomoebae with strains of Legionella . (A) Amoeba liquid cocultures were set up in saline with approximately 10 4 amoebae/ml and 10 3 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml.

    Techniques:

    Intraperitoneal inoculation of Legionella strains

    Journal:

    Article Title: Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae

    doi:

    Figure Lengend Snippet: Intraperitoneal inoculation of Legionella strains

    Article Snippet: The mean number of CFU (± standard deviations) was determined for each time point, and the Student-Newman-Keuls comparison of means ( P < 0.05) was used to determine statistical significance. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3 caption a7 Coculture of Acanthomoebae with strains of Legionella . (A) Amoeba liquid cocultures were set up in saline with approximately 10 4 amoebae/ml and 10 3 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml.

    Techniques:

    Aerosol inoculation of Legionella strains

    Journal:

    Article Title: Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae

    doi:

    Figure Lengend Snippet: Aerosol inoculation of Legionella strains

    Article Snippet: The mean number of CFU (± standard deviations) was determined for each time point, and the Student-Newman-Keuls comparison of means ( P < 0.05) was used to determine statistical significance. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3 caption a7 Coculture of Acanthomoebae with strains of Legionella . (A) Amoeba liquid cocultures were set up in saline with approximately 10 4 amoebae/ml and 10 3 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml.

    Techniques:

    Percentage weight gain or loss in guinea pigs exposed to an aerosol of different strains of Legionella longbeachae serogroup 1. (A) Animals exposed to a dose of 109 L. longbeachae serogroup 1 A5H5 organisms; (B) animals exposed to a dose of 109 B8 organisms; (C) animals exposed to a dose of 1010 B8 organisms; (D) animals exposed to a dose of 109 B8.22 organisms. Guinea pig death is indicated by the termination of the ribbon graph prior to the end of the experiment on day 7.

    Journal:

    Article Title: Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae

    doi:

    Figure Lengend Snippet: Percentage weight gain or loss in guinea pigs exposed to an aerosol of different strains of Legionella longbeachae serogroup 1. (A) Animals exposed to a dose of 109 L. longbeachae serogroup 1 A5H5 organisms; (B) animals exposed to a dose of 109 B8 organisms; (C) animals exposed to a dose of 1010 B8 organisms; (D) animals exposed to a dose of 109 B8.22 organisms. Guinea pig death is indicated by the termination of the ribbon graph prior to the end of the experiment on day 7.

    Article Snippet: The mean number of CFU (± standard deviations) was determined for each time point, and the Student-Newman-Keuls comparison of means ( P < 0.05) was used to determine statistical significance. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 3 caption a7 Coculture of Acanthomoebae with strains of Legionella . (A) Amoeba liquid cocultures were set up in saline with approximately 10 4 amoebae/ml and 10 3 CFU (each) of L. pneumophila serogroup 1 (Philadelphia) (⧫), L. longbeachae serogroup 1 ATCC 33462 (▪), B10 (▵), A5H5 (•), and B8 (×) per ml.

    Techniques:

    Analysis of virulence of L. longbeachae serogroup 1 strains in a guinea pig model of infection

    Journal:

    Article Title: Comparison of Virulence of Legionella longbeachae Strains in Guinea Pigs and U937 Macrophage-Like Cells

    doi: 10.1128/IAI.69.9.5335-5344.2001

    Figure Lengend Snippet: Analysis of virulence of L. longbeachae serogroup 1 strains in a guinea pig model of infection

    Article Snippet: Relatively few ATCC 33462 bacteria were seen in comparison to A5H5, most likely due to clearance of bacteria from the lung, since this strain is avirulent in an animal model ( 12 ).

    Techniques:

    Infectivities of Legionella for U937 cells

    Journal:

    Article Title: Comparison of Virulence of Legionella longbeachae Strains in Guinea Pigs and U937 Macrophage-Like Cells

    doi: 10.1128/IAI.69.9.5335-5344.2001

    Figure Lengend Snippet: Infectivities of Legionella for U937 cells

    Article Snippet: Relatively few ATCC 33462 bacteria were seen in comparison to A5H5, most likely due to clearance of bacteria from the lung, since this strain is avirulent in an animal model ( 12 ).

    Techniques:

    Electron micrograph showing the intracellular location of L. longbeachae serogroup 1 strains. Lungs were taken from a guinea pig infected with strains ATCC 33462 and A5H5, 3 days after exposure. (A) L. longbeachae serogroup 1 strain A5H5 bacteria (B) observed in a membrane bound vacuole within a macrophage. Potential ribosome studding of the vacuole membrane is shown by an arrow. Host organelles such as mitochondria (M) appear associated with the vacuole. Magnification, ×9,540; bar, 1 μm. (B) Ultrathin sections of a vacuole containing several A5H5 bacteria. Magnification, ×6,360; bar, 1 μm. (C) Macrophage with four membrane vacuoles, each containing one L. longbeachae serogroup 1 ATCC 33462 bacterium. Magnification, ×23,850; bar, 0.5 μm. The arrow indicates the macrophage membrane. (D) Phagosome within a macrophage containing several ATCC 33462 bacteria. The membrane of the vacuole appears smooth walled. Magnification, ×19,875; bar, 0.5 μm. The arrow indicates the phagosome membrane.

    Journal:

    Article Title: Comparison of Virulence of Legionella longbeachae Strains in Guinea Pigs and U937 Macrophage-Like Cells

    doi: 10.1128/IAI.69.9.5335-5344.2001

    Figure Lengend Snippet: Electron micrograph showing the intracellular location of L. longbeachae serogroup 1 strains. Lungs were taken from a guinea pig infected with strains ATCC 33462 and A5H5, 3 days after exposure. (A) L. longbeachae serogroup 1 strain A5H5 bacteria (B) observed in a membrane bound vacuole within a macrophage. Potential ribosome studding of the vacuole membrane is shown by an arrow. Host organelles such as mitochondria (M) appear associated with the vacuole. Magnification, ×9,540; bar, 1 μm. (B) Ultrathin sections of a vacuole containing several A5H5 bacteria. Magnification, ×6,360; bar, 1 μm. (C) Macrophage with four membrane vacuoles, each containing one L. longbeachae serogroup 1 ATCC 33462 bacterium. Magnification, ×23,850; bar, 0.5 μm. The arrow indicates the macrophage membrane. (D) Phagosome within a macrophage containing several ATCC 33462 bacteria. The membrane of the vacuole appears smooth walled. Magnification, ×19,875; bar, 0.5 μm. The arrow indicates the phagosome membrane.

    Article Snippet: Relatively few ATCC 33462 bacteria were seen in comparison to A5H5, most likely due to clearance of bacteria from the lung, since this strain is avirulent in an animal model ( 12 ).

    Techniques: Infection